Overall MS patients (and consistently the different clinical forms) present significantly higher levels of OPN in CSF than the combined group of healthy controls and no other neurological diseases, but only PPMS patients present higher levels in CSF than patients with other neurological diseases. The gene discussed is SPP1; the disease is myeloid sarcoma.